The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immuno-genic compositions such as vaccines for the treatment and/or prevention of RSV infection.
申请公布号
EP2370099(B1)
申请公布日期
2016.04.20
申请号
EP20090836751
申请日期
2009.12.09
申请人
NOVAVAX, INC.
发明人
PUSHKO, PETER;WU, YINGYUN;MASSARE, MICHAEL;LIU, YE;SMITH, GALE;ZHOU, BIN